Jiangsu Yahong Meditech Co. Ltd.
Industry
- Pharmaceuticals
See more in Biomedtracker
Latest on Jiangsu Yahong Meditech Co. Ltd.
In Vivo
• By Deanna Kamienski and Maureen Riordan
Biopharma Financing Biopharma financings during the fourth quarter of 2022 totaled $17.5bn from 282 deals; of those, 53 financings met or exceeded the $100m mark. Overall, follow on public offerings (
Scrip
• By Dexter Jie Yan
Jiangsu Yahong Meditech Co. Ltd. (previously Asieris Pharma), a clinical-stage Chinese biotech focused on small molecules for bladder cancer, has become the first Chinese drug maker to go public in 2